Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,399
Total Claims
$2.3M
Drug Cost
375
Beneficiaries
$6,078
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,928 Gastroenterology providers
+211%
Cost per patient vs peers
$6,078 vs $1,956 avg
+55%
Brand preference vs peers
22.3% vs 14.4% avg
Brand vs Generic
Brand: 312 claims · $2.2M
Generic: 1,087 claims · $61K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Teduglutide | 27 | $1.6M |
| Infliximab | 13 | $143K |
| Tofacitinib Citrate | 11 | $67K |
| Linaclotide | 54 | $56K |
| Rifaximin | 16 | $50K |
| Lipase/Protease/Amylase | 15 | $34K |
| Sod Picosulf/Mag Ox/Citric Ac | 47 | $8,267 |
| Pantoprazole Sodium | 290 | $5,805 |
| Mesalamine | 12 | $5,196 |
| Lactulose | 48 | $4,955 |
| Budesonide | 20 | $4,781 |
| Sodium, Potassium,mag Sulfates | 57 | $4,648 |
| Lubiprostone | 12 | $4,012 |
| Budesonide | 26 | $3,886 |
| Omeprazole | 113 | $2,006 |
Prescribing Profile
27
Unique Drugs
3.0
Anomaly Score
Patient Profile
71
Avg Age
58%
Female
1.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About